Biogen, Inc. (BIIB)
187.62
+1.62
(+0.87%)
USD |
NASDAQ |
Jan 09, 16:00
188.02
+0.40
(+0.21%)
After-Hours: 20:00
Biogen Price: 187.62 for Jan. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1063.56 |
| Stoke Therapeutics, Inc. | 32.85 |
| AbbVie, Inc. | 220.08 |
| Alnylam Pharmaceuticals, Inc. | 398.29 |
| Insmed, Inc. | 175.97 |
Price Related Metrics
| PE Ratio | 17.11 |
| PS Ratio | 2.839 |
| Price to Book Value | 1.512 |
| Price to Free Cash Flow | 12.16 |
| Earnings Yield | 5.84% |
| Market Cap | 27.52B |
| Operating PE Ratio | 11.28 |
| Normalized PE Ratio | 15.17 |